STERIS Operating Income 2012-2025 | STE
STERIS annual/quarterly operating income history and growth rate from 2012 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- STERIS operating income for the quarter ending September 30, 2025 was $0.266B, a 20.98% increase year-over-year.
- STERIS operating income for the twelve months ending September 30, 2025 was $0.973B, a 14.23% increase year-over-year.
- STERIS annual operating income for 2025 was $0.867B, a 3.65% increase from 2024.
- STERIS annual operating income for 2024 was $0.836B, a 5.69% increase from 2023.
- STERIS annual operating income for 2023 was $0.791B, a 65.57% increase from 2022.
|
STERIS Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $867 |
| 2024 | $836 |
| 2023 | $791 |
| 2022 | $478 |
| 2021 | $548 |
| 2020 | $537 |
| 2019 | $411 |
| 2018 | $400 |
| 2017 | $226 |
| 2016 | $213 |
| 2015 | $227 |
| 2014 | $207 |
| 2013 | $243 |
| 2012 | $222 |
| 2011 | $85 |
|
STERIS Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $266 |
| 2025-06-30 | $246 |
| 2025-03-31 | $216 |
| 2024-12-31 | $245 |
| 2024-09-30 | $220 |
| 2024-06-30 | $186 |
| 2024-03-31 | $220 |
| 2023-12-31 | $226 |
| 2023-09-30 | $192 |
| 2023-06-30 | $198 |
| 2023-03-31 | $748 |
| 2022-12-31 | $191 |
| 2022-09-30 | $-306 |
| 2022-06-30 | $158 |
| 2022-03-31 | $144 |
| 2021-12-31 | $203 |
| 2021-09-30 | $117 |
| 2021-06-30 | $14 |
| 2021-03-31 | $144 |
| 2020-12-31 | $147 |
| 2020-09-30 | $141 |
| 2020-06-30 | $116 |
| 2020-03-31 | $158 |
| 2019-12-31 | $142 |
| 2019-09-30 | $127 |
| 2019-06-30 | $110 |
| 2019-03-31 | $140 |
| 2018-12-31 | $70 |
| 2018-09-30 | $107 |
| 2018-06-30 | $94 |
| 2018-03-31 | $113 |
| 2017-12-31 | $103 |
| 2017-09-30 | $99 |
| 2017-06-30 | $85 |
| 2017-03-31 | $57 |
| 2016-12-31 | $26 |
| 2016-09-30 | $70 |
| 2016-06-30 | $74 |
| 2016-03-31 | $99 |
| 2015-12-31 | $47 |
| 2015-09-30 | $23 |
| 2015-06-30 | $44 |
| 2015-03-31 | $68 |
| 2014-12-31 | $61 |
| 2014-09-30 | $53 |
| 2014-06-30 | $44 |
| 2014-03-31 | $60 |
| 2013-12-31 | $56 |
| 2013-09-30 | $50 |
| 2013-06-30 | $41 |
| 2013-03-31 | $65 |
| 2012-12-31 | $67 |
| 2012-09-30 | $62 |
| 2012-06-30 | $48 |
| 2012-03-31 | $74 |
| 2011-12-31 | $54 |
| 2011-09-30 | $48 |
| 2011-06-30 | $47 |
| 2011-03-31 | $57 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $25.607B | $5.460B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $240.247B | 28.55 |
| Intuitive Surgical (ISRG) | United States | $188.491B | 72.03 |
| IDEXX Laboratories (IDXX) | United States | $55.181B | 54.80 |
| Edwards Lifesciences (EW) | United States | $49.001B | 32.86 |
| IQVIA Holdings (IQV) | United States | $40.710B | 22.70 |
| Alcon (ALC) | Switzerland | $40.074B | 27.01 |
| Mettler-Toledo (MTD) | United States | $29.378B | 34.37 |
| DexCom (DXCM) | United States | $28.830B | 39.74 |
| Waters (WAT) | United States | $23.844B | 31.53 |
| Coloplast (CLPBY) | Denmark | $19.494B | 33.27 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.744B | 0.00 |
| Hologic (HOLX) | United States | $16.742B | 17.59 |
| Penumbra (PEN) | United States | $14.041B | 98.77 |
| Globus Medical (GMED) | United States | $12.667B | 26.58 |
| Masimo (MASI) | United States | $7.731B | 24.77 |
| Glaukos (GKOS) | United States | $7.231B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.112B | 19.42 |
| TransMedics (TMDX) | United States | $4.719B | 55.91 |
| Teleflex (TFX) | United States | $4.644B | 7.40 |
| LivaNova (LIVN) | United Kingdom | $3.488B | 18.84 |
| Veracyte (VCYT) | United States | $3.462B | 39.46 |
| Integer Holdings (ITGR) | United States | $2.997B | 14.07 |
| Elekta AB (EKTAY) | Sweden | $2.473B | 23.14 |
| Alphatec Holdings (ATEC) | United States | $2.347B | 0.00 |
| Artivion (AORT) | United States | $2.081B | 95.48 |
| UFP Technologies (UFPT) | United States | $2.057B | 27.15 |
| Nihon Kohden (NHNKY) | Japan | $2.028B | 17.70 |
| PROCEPT BioRobotics (PRCT) | United States | $1.717B | 0.00 |
| AxoGen (AXGN) | United States | $1.476B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.396B | 0.00 |
| IRadimed (IRMD) | United States | $1.322B | 62.96 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.986B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.950B | 5.14 |
| Pacific Biosciences Of California (PACB) | United States | $0.806B | 0.00 |
| SiBone (SIBN) | United States | $0.734B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.727B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.667B | 38.78 |
| Alpha Tau Medical (DRTS) | Israel | $0.608B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.608B | 12.13 |
| NeuroPace (NPCE) | United States | $0.568B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.548B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.477B | 13.18 |
| OrthoPediatrics (KIDS) | United States | $0.464B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.438B | 0.00 |
| RxSight (RXST) | United States | $0.405B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.388B | 64.59 |
| Sight Sciences (SGHT) | United States | $0.339B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Anteris Technologies Global (AVR) | Australia | $0.271B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.270B | 0.00 |
| 908 Devices (MASS) | United States | $0.253B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.203B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.195B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Neuronetics (STIM) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.135B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.133B | 0.00 |
| Solana (HSDT) | United States | $0.133B | 0.00 |
| Hyperfine (HYPR) | United States | $0.121B | 0.00 |
| Accuray (ARAY) | United States | $0.094B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.085B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.74 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |